MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease

Clinical trial NCT00374296 · TERMINATED

Trial details

NCT number: NCT00374296
Sponsor: Mirati Therapeutics Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelogenous Leukemia, Acute Myelodysplastic Syndromes

Start date: 2006-09-01
Primary completion: 2008-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.